These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16331723)

  • 1. Willingness to pay for reductions in health risks when probabilities are distorted.
    Bleichrodt H; Eeckhoudt L
    Health Econ; 2006 Feb; 15(2):211-4. PubMed ID: 16331723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of real options on willingness to pay for mortality risk reductions.
    Krüger NA; Svensson M
    J Health Econ; 2009 May; 28(3):563-9. PubMed ID: 19261344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subject variation more than values clarification explains the reliability of willingness to pay estimates.
    Shiell A; McIntosh K
    Health Econ; 2008 Feb; 17(2):287-92. PubMed ID: 17619235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidities and the willingness to pay for reducing the risk of a targeted disease: introducing endogenous effort for risk reduction.
    Liu L
    Health Econ; 2004 May; 13(5):493-8. PubMed ID: 15127428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of risk representation and scope on willingness to pay for reduced risks: evidence from Tokyo Bay, Japan.
    Zhai G; Suzuki T
    Risk Anal; 2008 Apr; 28(2):513-22. PubMed ID: 18419666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for health risk reduction in the context of altruism.
    Araña JE; León CJ
    Health Econ; 2002 Oct; 11(7):623-35. PubMed ID: 12369063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Household health-seeking behaviour in Khartoum, Sudan: the willingness to pay for public health services if these services are of good quality.
    Habbani K; Groot W; Jelovac I
    Health Policy; 2006 Jan; 75(2):140-58. PubMed ID: 15979193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits transfer of willingness to pay estimates and functions for health-risk reductions: a cross-country study.
    Brouwer R; Bateman IJ
    J Health Econ; 2005 May; 24(3):591-611. PubMed ID: 15811545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay for praziquantel treatment in a hyperendemic community of Ogun State, Nigeria.
    Adeneye AK; Mafe MA; Appelt B; Idowu ET; Akande DO
    Res Social Adm Pharm; 2006 Mar; 2(1):83-95. PubMed ID: 17138502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay for weight-control treatment.
    Liu JT; Tsou MW; Hammitt JK
    Health Policy; 2009 Jul; 91(2):211-8. PubMed ID: 19167128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of approaches to estimating confidence intervals for willingness to pay measures.
    Hole AR
    Health Econ; 2007 Aug; 16(8):827-40. PubMed ID: 17238222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods.
    Ryan M; Scott DA; Donaldson C
    J Health Econ; 2004 Mar; 23(2):237-58. PubMed ID: 15019754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the shape of the probability weighting function.
    Gonzalez R; Wu G
    Cogn Psychol; 1999 Feb; 38(1):129-66. PubMed ID: 10090801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Women's willingness to pay for cancer screening].
    Kwak MS; Sung NY; Yang JH; Park EC; Choi K
    J Prev Med Public Health; 2006 Jul; 39(4):331-8. PubMed ID: 16910307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using assessment of willingness to pay to improve a Cambodian spectacle service.
    Ramke J; Palagyi A; du Toit R; Brian G
    Br J Ophthalmol; 2008 Feb; 92(2):170-4. PubMed ID: 18211947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of stated preference methods for estimating monetary values.
    Ryan M
    Health Econ; 2004 Mar; 13(3):291-6. PubMed ID: 14981653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we estimate the 'social' value of a QALY? Four core issues to resolve.
    Smith RD; Richardson J
    Health Policy; 2005 Sep; 74(1):77-84. PubMed ID: 16098414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk individuals' willingness to pay for diabetes risk-reduction programs.
    Johnson FR; Manjunath R; Mansfield CA; Clayton LJ; Hoerger TJ; Zhang P
    Diabetes Care; 2006 Jun; 29(6):1351-6. PubMed ID: 16732020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring.
    Schwarzinger M; Carrat F; Luchini S
    J Health Econ; 2009 Jul; 28(4):873-84. PubMed ID: 19362383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.